Christopher Bellamy
- Transplantation top 1%
- Renal Transplantation Outcomes and Treatments 11
- Hepatology top 2%
- Liver Disease and Transplantation 8
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Oncology top 2%
- Cancer-related Molecular Pathways 7
- Viral-associated cancers and disorders 5
- Cancer Research top 5%
-
- Organ Transplantation Techniques and Outcomes 11
-
- Renal Diseases and Glomerulopathies 8
-
- Liver Disease Diagnosis and Treatment 5
- Co-authors
- David J. HarrisonWilliam R. MillerSandrine ProstAndrew H. WyllieThomas AndersonDavid KluthU ChettyC. McDonald
- Cited by
- TransplantationHepatologyOncology
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Christopher Bellamy
88 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 135
- Transplantation 246
- Hepatology 509
- Oncology 1.1k
- Cancer Research 521
- Pathology and Forensic Medicine 597
Countries citing papers authored by Christopher Bellamy
This map shows the geographic impact of Christopher Bellamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Bellamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Bellamy more than expected).
Fields of papers citing papers by Christopher Bellamy
This network shows the impact of papers produced by Christopher Bellamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Bellamy. The network helps show where Christopher Bellamy may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christopher Bellamy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2016 | 12 | |
| 3 | 2014 | 100 | |
| 4 | European Union law of competition | 2013 | 4 |
| 5 | 2012 | 25 | |
| 6 | 2012 | 24 | |
| 7 | 2009 | 17 | |
| 8 | 2009 | 26 | |
| 9 | 2007 | 43 | |
| 10 | 2007 | 38 | |
| 11 | 2005 | 225 | |
| 12 | Focusing on the European Perspective of Judicial Dialogue: Issues in the Area of Competition Law | 2004 | 1 |
| 13 | 2004 | 33 | |
| 14 | European Community law of competition | 2001 | 15 |
| 15 | 2001 | 8 | |
| 16 | 2001 | 81 | |
| 17 | 2001 | 119 | |
| 18 | The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer | 2000 | 4 |
| 19 | 2000 | 7 | |
| 20 | 1997 | 50 |
About Christopher Bellamy
Christopher Bellamy is a scholar working on Transplantation, Hepatology, Nephrology, Oncology and Genetics, having authored 96 papers that have together received 3.4k indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (11 papers), Organ Transplantation Techniques and Outcomes (11 papers), Renal Diseases and Glomerulopathies (8 papers), Liver Disease and Transplantation (8 papers), Cancer-related Molecular Pathways (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Viral-associated cancers and disorders (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). The work is most often cited by research in Transplantation (246 citations), Hepatology (509 citations), Oncology (1.1k citations), Cancer Research (521 citations) and Pathology and Forensic Medicine (597 citations). Christopher Bellamy has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include David J. Harrison, William R. Miller, Sandrine Prost, Andrew H. Wyllie, Thomas Anderson, David Kluth, U Chetty, C. McDonald, Donald M. Salter and Andrew H. Wyllie. Their work appears in journals such as Histopathology, Transplantation, PLoS ONE, American Journal of Transplantation and Kidney International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.